Key Takeaways
- UiPath shares declined 7.7% Wednesday, reaching an intraday low of $11.00 from a previous close of $12.04.
- Trading activity was exceptionally light, coming in 85% under typical session volume.
- Analyst consensus leans toward “Hold” ratings, with an average price target of $13.80.
- Fourth-quarter revenue reached $418.38 million, representing 17.3% annual growth and exceeding projections.
- Convergence Investment Partners established a fresh $4.4 million stake in PATH during the first quarter.
Shares of UiPath (PATH) tumbled 7.7% during Wednesday’s session, dipping to an intraday low of $11.00 before settling at $11.11. The automation software company closed at $12.04 the previous day.
The decline became particularly notable due to exceptionally light trading activity. Approximately 6.4 million shares exchanged hands—a significant 85% decline from the typical daily volume of 41.4 million shares. Such reduced liquidity can amplify price movements and create exaggerated volatility.
Technical indicators show the stock’s 50-day moving average positioned at $11.11, while the 200-day moving average rests at $11.75. The company currently maintains a market capitalization of roughly $5.50 billion.
Analyst Sentiment Remains Reserved
Wall Street’s outlook on PATH remains predominantly neutral. Among 17 equity analysts tracking the stock, 14 maintain “Hold” recommendations, while two suggest “Buy” and one advises “Sell.” The average price target stands at $13.80.
Recent analyst activity has trended downward. BMO Capital Markets reduced its price objective from $14 to $13 while maintaining a “market perform” stance. Morgan Stanley lowered its forecast from $17 to $15, accompanied by an “equal weight” designation. UBS revised its target downward from $13 to $12 while retaining a “neutral” outlook. Bank of America made a modest upward adjustment from $12 to $13 but continues to rate the stock “underperform.”
Needham stands as the most bullish voice, maintaining its “buy” recommendation with a $15 price objective.
Quarterly Results Exceeded Expectations
Wednesday’s sell-off appears disconnected from PATH‘s fundamentals, as the company reported encouraging results in late May. Quarterly revenue totaled $418.38 million, substantially surpassing analyst projections of $397.54 million. This figure marked a robust 17.3% increase compared to the prior-year period.
Earnings per share landed at $0.15, meeting Street expectations precisely. The comparable quarter a year earlier produced $0.11 per share. The company achieved a net profit margin of 19.58% alongside a return on equity of 7.92%.
Looking ahead, Wall Street forecasts full-year earnings of $0.40 per share.
Over the past 52 weeks, PATH has traded between $9.20 and $19.84—placing Wednesday’s closing price significantly below its recent peak performance.
Regarding institutional activity, Convergence Investment Partners opened a new position during the first quarter, acquiring 396,363 shares valued at approximately $4.4 million, representing roughly 0.08% ownership. Institutional shareholders collectively control 62.50% of outstanding shares.
Additional investment firms, including HighMark Wealth Management, Raleigh Capital Management, and Atlas Capital Advisors, also initiated modest positions in the fourth quarter, though each valued below $40,000.
PATH concluded Wednesday’s trading at $11.11, hovering near its 50-day moving average threshold.
